These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 17976740)

  • 21. VNS and depression: current status and future directions.
    Walsh SP; Kling MA
    Expert Rev Med Devices; 2004 Sep; 1(1):155-60. PubMed ID: 16293018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vagus nerve stimulation therapy for treatment of drug-resistant epilepsy and depression.
    Shafique S; Dalsing MC
    Perspect Vasc Surg Endovasc Ther; 2006 Dec; 18(4):323-7. PubMed ID: 17351201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vagus nerve stimulation for the treatment of depression and other neuropsychiatric disorders.
    George MS; Nahas Z; Borckardt JJ; Anderson B; Burns C; Kose S; Short EB
    Expert Rev Neurother; 2007 Jan; 7(1):63-74. PubMed ID: 17187498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Electroconvulsive therapy in patients with vagus nerve stimulation.
    Sharma A; Chaturvedi R; Sharma A; Sorrell JH
    J ECT; 2009 Jun; 25(2):141-3. PubMed ID: 18665100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Vagus nerve stimulation in severe, treatment-resistent depression].
    Gorczyca I; Zwoliński P; Roszkowsk Mi; Niemcewicz S
    Psychiatr Pol; 2006; 40(6):1137-42. PubMed ID: 17444293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Right-sided vagus nerve stimulation in humans: an effective therapy?
    Spuck S; Nowak G; Renneberg A; Tronnier V; Sperner J
    Epilepsy Res; 2008 Dec; 82(2-3):232-4. PubMed ID: 18801642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Concentration of soluble forms of selectins in serum and in cerebrospinal fluid in group of patients with neuroborreliosis--a preliminary study].
    Moniuszko AM; Pancewicz SA; Kondrusik M; Zajkowska J; Grygorczuk S; Swierzbińska R
    Pol Merkur Lekarski; 2007 Sep; 23(135):174-8. PubMed ID: 18080689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Left vagus nerve stimulation for depression: first implantation case post-fDA approval and review of the literature.
    Patwardhan R; Cardenas R; Myers D; Ware P; Nanda A
    J La State Med Soc; 2007; 159(1):38-41. PubMed ID: 17396474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma and cerebrospinal fluid substance P in post-stroke patients with depression.
    Li L; Gao X; Zhao J; Ji X; Wei H; Luo Y
    Psychiatry Clin Neurosci; 2009 Jun; 63(3):298-304. PubMed ID: 19566760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Central therapeutic effects of peripheral vagus nerve stimulation.
    Gross M; Goyal M
    Am J Electroneurodiagnostic Technol; 2007 Mar; 47(1):47-52. PubMed ID: 17503610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vagus nerve stimulation in a patient with Gilles de la Tourette syndrome and major depression.
    Sperling W; Reulbach U; Maihöfner C; Kornhuber J; Bleich S
    Pharmacopsychiatry; 2008 May; 41(3):117-8. PubMed ID: 18484555
    [No Abstract]   [Full Text] [Related]  

  • 32. Vagal nerve stimulation versus deep brain stimulation for treatment-resistant depression: show me the data.
    Henderson JM
    Clin Neurosurg; 2007; 54():88-90. PubMed ID: 18504902
    [No Abstract]   [Full Text] [Related]  

  • 33. Vagus nerve stimulation therapy in a patient with treatment-resistant depression: a case report of long-term follow-up and battery end-of-service.
    Martinez JM; Zboyan HA
    CNS Spectr; 2006 Feb; 11(2):143-7. PubMed ID: 16520692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Repetitive transcranial magnetic stimulation (rTMS) in combination with escitalopram in patients with treatment-resistant major depression: a double-blind, randomised, sham-controlled trial.
    Bretlau LG; Lunde M; Lindberg L; Undén M; Dissing S; Bech P
    Pharmacopsychiatry; 2008 Mar; 41(2):41-7. PubMed ID: 18311683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical benefits and cost effectiveness of vagus nerve stimulation in a long-term treatment of patients with major depression.
    Sperling W; Reulbach U; Kornhuber J
    Pharmacopsychiatry; 2009 May; 42(3):85-8. PubMed ID: 19452375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased cerebrospinal fluid levels of substance P in patients with Rett syndrome.
    Matsuishi T; Nagamitsu S; Yamashita Y; Murakami Y; Kimura A; Sakai T; Shoji H; Kato H; Percy AK
    Ann Neurol; 1997 Dec; 42(6):978-81. PubMed ID: 9403492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vagus nerve stimulation (VNS) for treatment-resistant depression.
    Topfer LA; Hailey D
    Issues Emerg Health Technol; 2001 Oct; (25):1-4. PubMed ID: 11902224
    [No Abstract]   [Full Text] [Related]  

  • 38. Vagus nerve stimulation in the treatment of pharmacoresistant depression.
    Hotujac L; Kuzman MR
    Neuro Endocrinol Lett; 2008 Nov; 29 Suppl 1():133-46. PubMed ID: 19029870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebrospinal fluid corticotropin-releasing factor and perceived early-life stress in depressed patients and healthy control subjects.
    Carpenter LL; Tyrka AR; McDougle CJ; Malison RT; Owens MJ; Nemeroff CB; Price LH
    Neuropsychopharmacology; 2004 Apr; 29(4):777-84. PubMed ID: 14702025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment-resistant depression: critique of current approaches.
    Wijeratne C; Sachdev P
    Aust N Z J Psychiatry; 2008 Sep; 42(9):751-62. PubMed ID: 18696279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.